The diagnostic ability of the Japanese version of the high bleeding risk (J-HBR) criteria in patients with lower extremity peripheral arterial disease remains unclear.
Does the Japanese version of the high bleeding risk (J-HBR) criteria predict major bleeding and ischemic events in patients with lower extremity arterial disease undergoing endovascular treatment?
The J-HBR criteria successfully stratifies ischemic risk, though not significantly for bleeding risk, in Japanese patients with lower extremity arterial disease undergoing endovascular treatment.
Background: The Japanese version of the high bleeding risk (J-HBR) criteria was proposed to identify Japanese patients at HBR after percutaneous coronary intervention. However, the diagnostic ability of the J-HBR in patients with lower extremity peripheral arterial disease (LEAD) remains unclear.
Matsumoto et al. (2026) studied this question. The diagnostic ability of the Japanese version of the high bleeding risk (J-HBR) criteria in patients with lower extremity peripheral arterial disease remains unclear.